• Home
  • NEW DAY MEDICINE
  • 6 (68) 2024
  • 4 -6 (68) 2024 - Jalilova D.M., Shavazi N.N. - FORECASTING AND PREVENTION OF FETOPLASENTAR DEFICIENCY IN PREGNANT WOMEN WITH PRETERM OBSTETRIC CARE

4 -6 (68) 2024 - Jalilova D.M., Shavazi N.N. - FORECASTING AND PREVENTION OF FETOPLASENTAR DEFICIENCY IN PREGNANT WOMEN WITH PRETERM OBSTETRIC CARE

THE ROLE OF CLOSTRIDIUM DIFFICILE IN THE DEVELOPMENT OF ANTIBIOTIC-RELATED DIARRHEA IN YOUNG CHILDREN

Jalilova D.M. - Samarkand State Medical University Uzbekistan

Shavazi N.N. - Samarkand State Medical University Uzbekistan

Resume

The lack of a Fetoplasentary system remains one of the pressing problems of modern obstetrics to this day. Fetoplasentar insufficiency is a complex of morphofunctional diseases of the placenta, which develop from the fetus and placenta due to various extragenital and gynecological pathologies, as well as complications of pregnancy caused by infectious viral, bacterial diseases, endocrine, exogenous factors at the stage of placenta formation and Organogenesis. Complications from Fetoplasentar insufficiency include delayed fetal intrauterine development syndrome, acute and chronic fetal hypoxia, premature placental aging, underdeveloped pregnancy. Premature FPY, which leads to impaired placentation and underdevelopment of the placenta, is one of the causes of premature birth. Among all births, the FPY rate reaches 20-30%, and in cases of premature birth it reaches 23%. Therefore, at present, in modern obstetrics, the application and introduction into clinical practice of modern diagnostic methods, which allow to identify pathological changes in the fetoplasentar complex at the pre-clinical stage, remains a priority.

Keywords: premature labor,fetoplasentar insufficiency, morphofunctional diseases of the placenta,extragenital diseases, ferroptosis, glutathione peroxidase 4, arginine.

First page

18

Last page

24

For citation:Jalilova D.M., Shavazi N.N. - FORECASTING AND PREVENTION OF FETOPLASENTAR DEFICIENCY IN PREGNANT WOMEN WITH PRETERM OBSTETRIC CARE//New Day in Medicine 6(68)2024 18-24 https://newdayworldmedicine.com/en/article/3758

List of References

  1. Farmonova R.F., Akhtamova N.A. (2022, December). Muddatdan oldingi tugruqda platsentaning morfofunksional tuzilishi. In international conferences 2022;1(18):148-150.
  2. Тезиков, Ю. В., Липатов, И. С., Азаматов, А. Р. (2021). Гормонально-метаболический паттерн доклинической стадии преэклампсии. //Журнал акушерства и женских болезней 2021;70(3):51-63.
  3. Хурасева А. Б. (2009). Роль синдрома задержки внутриутробного развития плода в генезе клинических проявлений дисплазии соединительной ткани у девочек-подростков. //Журнал акушерства и женских болезней, 2029;58(6):65-69.
  4. Худоярова Д., Абдуллаева, Ш. (2023). Фетоплацентарная недостаточность и гипотония у беременных (литературный обзор). //Евразийский журнал медицинских и естественных наук, 2023;3(1 Part 2):121-130.
  5. Newnham, J. P., Godfrey, M., Walters, B. J., Phillips, J., Evans, S. F. (1995). Low dose aspirin for the treatment of fetal growth restriction: a randomized controlled trial. Australian and New Zealand journal of obstetrics and gynaecology, 1995;35(4), 370-374.
  6. Oyelese K. O., Black R. S., Lees C. C., Campbell, S. (1998). A novel approach to the management of pregnancies complicated by uteroplacental insufficiency and previous stillbirth. //Australian and New Zealand journal of obstetrics and gynaecology, 1998;38(4):391-395.
  7. Сидельникова В. М., Сухих Г. Т. (1999). Актуальные проблемы невынашивания беременности. //Цикл лекций, 1999;37-41.
  8. Бычков В. И., Образцова Е. Е., Шамарин С. В. (1999). Диагностика и лечение хронической фетоплацентарной недостаточности. Акушерство и гинекология, 1999;6:3-6.
  9. Мурашко Л. Е., Бадоева Ф. С., Асымбекова Г. У., Павлович С. В. (1996). Перинатальные исходы при хронической плацентарной недостаточности. //Акушерство и гинекология, 1996;(4):43-44.
  10. Зарубина Е. Н., Бермишева О. А., Смирнова А. А. (2000). Современные подходы к лечению хронической фетоплацентарной недостаточности. //Проблемы репродукции 2000;5:61-63.
  11. Sattarova N., Shavazi N. (2024). Perinatal risk of premature birth: new obstetric opportunities. //International Journal of Medical Sciences And Clinical Research, 2024;4(02), 41-51.
  12. Nuralievna S.N. (2023). Evaluation of markers of endothelial dysfunction in placental apoptosis in women with preterm labor. //Scientific Journal Of Medical Science And Biology 2023; 1(1): 292-299.
  13. Sande, A. K., Torkildsen, E. A., Sande, R. K., Dalen, I., Danielsson, K. C., Morken, N. H. (2022). Use of antihistamines before or during pregnancy and risk of early-onset pre-eclampsia in allergic women: a population-based cohort study. //BMJ open, 2022;12(10):061837.
  14. Yawn, B., Knudtson, M. (2007). Treating asthma and comorbid allergic rhinitis in pregnancy. //The Journal of the American Board of Family Medicine, 2007;20(3):289-298.
  15. Курбачева, О. М., Швец, С. М. (2013). Аллергический ринит и беременность: возможности современной терапии. //Эффективная фармакотерапия, 2013;18:74-80.
  16. Рахимова, Г. Ш., Шамсиев, Д. Ф. (2023). Современные принципы профилактики и лечения беременных с аллергическим ринитом. //MedUnion, 2023;2(1):191-201.
  17. Купаев, В. И., Косарев, В. В., Жестков, А. В., Зайцева, С. А. (2003). Распространенность и пути контроля бронхиальной астмы и аллергического ринита у беременных. //Аллергология, 2003;(2):7-11.
  18. Beharier O., Kajiwara K., Sadovsky Y. (2021). Ferroptosis, trophoblast lipotoxic damage, and adverse pregnancy outcome. //Placenta, 2021;108:32-38.
  19. Morphofunctional structure of the placenta in premature labor. //Galaxy International Interdisciplinary Research Journal, 2021;10(4):381-384.
  20. Nuralievna S.N. (2023). Evaluation of markers of endothelial dysfunction in placental apoptosis in women with preterm labor. //Scientific Journal Of Medical Science And Biology, 2023;1(1):292-299.

    file

    download